Browse > Article
http://dx.doi.org/10.5230/jgc.2020.20.e34

Surgical Outcomes and Survival Prognostic Factors for Palliative Gastrectomies in Stage IV Resectable Gastric Cancer Outlet Obstruction Patients  

Choi, Won Yong (Department of Surgery, Konkuk University Chungju Hospital, Konkuk University School of Medicine)
Kim, Hyun Il (Department of Surgery, Hanyang University Guri Hospital, Hanyang University School of Medicine)
Park, Seong Ho (Department of Anesthesiology, Hanyang University Guri Hospital, Hanyang University School of Medicine)
Yeom, Jong Hoon (Department of Anesthesiology, Hanyang University Guri Hospital, Hanyang University School of Medicine)
Jeon, Woo Jae (Department of Anesthesiology, Hanyang University Guri Hospital, Hanyang University School of Medicine)
Kim, Min Gyu (Department of Surgery, Hanyang University Guri Hospital, Hanyang University School of Medicine)
Publication Information
Journal of Gastric Cancer / v.20, no.4, 2020 , pp. 421-430 More about this Journal
Abstract
Purpose: Currently, there is no clear evidence to support any specific treatment as a principal therapy for stage IV gastric cancer outlet obstruction (GCOO) patients. This study evaluated the outcomes of palliative gastrectomies and survival prognostic factors in patients with stage IV resectable GCOO. Materials and Methods: We retrospectively reviewed the medical records of 48 stage IV GCOO patients who underwent palliative gastrectomies between June 2010 and December 2019. Palliative gastrectomies were performed only in patients with resectable disease. Early surgical outcomes and prognostic factors were analyzed using univariate and multivariate analyses. Results: There were no specific risk factors for postoperative complications, except for being underweight. Severe postoperative complications developed in five patients, and most of the patients underwent interventional procedures and received broad-spectrum antibiotics for intra-abdominal abscesses. The multivariate survival analysis showed that palliative chemotherapy is a positive prognostic factor, while the specific type of hematogenous and lymphatic metastasis is a negative prognostic factor. Conclusions: We recommend that the treatment method for stage IV GCOO should be selected according to each patient's physical condition and tumor characteristics. In addition, we suggest that palliative gastrectomies can be performed in stage IV resectable GCOO patients without unfavorable prognostic factors (types of hematogenous and lymphatic metastases).
Keywords
Gastric cancer; Palliative care; Gastric outlet obstruction; Gastrectomy; Survival;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Fujitani K, Yang HK, Mizusawa J, Kim YW, Terashima M, Han SU, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol 2016;17:309-318.   DOI
2 Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg 2009;250:177-186.   DOI
3 Chen JH, Wu CW, Lo SS, Li AF, Hsieh MC, Shen KH, et al. Outcome of distal gastric cancer with pyloric stenosis after curative resection. Eur J Surg Oncol 2007;33:556-560.   DOI
4 Dittmar Y, Rauchfuss F, Goetz M, Jandt K, Scheuerlein H, Heise M, et al. Non-curative gastric resection for patients with stage 4 gastric cancer--a single center experience and current review of literature. Langenbecks Arch Surg 2012;397:745-753.   DOI
5 Bozzetti F, Bonfanti G, Audisio RA, Doci R, Dossena G, Gennari L, et al. Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 1987;164:151-154.
6 Maekawa S, Saku M, Maehara Y, Sadanaga N, Ikejiri K, Anai H, et al. Surgical treatment for advanced gastric cancer. Hepatogastroenterology 1996;43:178-186.
7 Ajisaka H, Fujita H, Kaji M, Maeda K, Yabushita K, Konishi K, et al. Treatment of patients with gastric cancer and duodenal invasion. Int Surg 2001;86:9-13.
8 Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean practice guideline for gastric cancer 2018: an evidence-based, multi-disciplinary approach. J Gastric Cancer 2019;19:1-48.   DOI
9 Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, et al. Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2016;14:1286-1312.   DOI
10 Lasithiotakis K, Antoniou SA, Antoniou GA, Kaklamanos I, Zoras O. Gastrectomy for stage IV gastric cancer. a systematic review and meta-analysis. Anticancer Res 2014;34:2079-2085.
11 Sun J, Song Y, Wang Z, Chen X, Gao P, Xu Y, et al. Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis. BMC Cancer 2013;13:577.   DOI
12 Chang YR, Han DS, Kong SH, Lee HJ, Kim SH, Kim WH, et al. The value of palliative gastrectomy in gastric cancer with distant metastasis. Ann Surg Oncol 2012;19:1231-1239.   DOI
13 Allison SP. Malnutrition, disease, and outcome. Nutrition 2000;16:590-593.   DOI
14 Samarasam I, Chandran BS, Sitaram V, Perakath B, Nair A, Mathew G. Palliative gastrectomy in advanced gastric cancer: is it worthwhile? ANZ J Surg 2006;76:60-63.   DOI
15 Sungurtekin H, Sungurtekin U, Balci C, Zencir M, Erdem E. The influence of nutritional status on complications after major intraabdominal surgery. J Am Coll Nutr 2004;23:227-232.   DOI
16 Park SH, Mok YJ, Kim JH, Park SS, Kim SJ, Kim CS. Clinical significance of gastric outlet obstruction on the oncologic and surgical outcomes of radical surgery for carcinoma of the distal stomach. J Surg Oncol 2009;100:215-221.   DOI
17 Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol 2002;97:72-78.   DOI
18 Lopera JE, Brazzini A, Gonzales A, Castaneda-Zuniga WR. Gastroduodenal stent placement: current status. Radiographics 2004;24:1561-1573.   DOI
19 Jeurnink SM, Steyerberg EW, Hof G, van Eijck CH, Kuipers EJ, Siersema PD. Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol 2007;96:389-396.   DOI
20 Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, van de Velde CJDutch Gastric Cancer Group. Value of palliative resection in gastric cancer. Br J Surg 2002;89:1438-1443.   DOI
21 Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, et al. Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 1998;69:41-44.   DOI
22 Doglietto GB, Pacelli F, Caprino P, Alfieri S, Carriero C, Malerba M, et al. Palliative surgery for faradvanced gastric cancer: a retrospective study on 305 consecutive patients. Am Surg 1999;65:352-355.
23 Shaw JM, Bornman PC, Krige JE, Stupart DA, Panieri E. Self-expanding metal stents as an alternative to surgical bypass for malignant gastric outlet obstruction. Br J Surg 2010;97:872-876.   DOI
24 Jeurnink SM, Steyerberg EW, van Hooft JE, van Eijck CH, Schwartz MP, Vleggaar FP, et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 2010;71:490-499.   DOI
25 Mehta S, Hindmarsh A, Cheong E, Cockburn J, Saada J, Tighe R, et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc 2006;20:239-242.   DOI
26 Keranen I, Kylanpaa L, Udd M, Louhimo J, Lepisto A, Halttunen J, et al. Gastric outlet obstruction in gastric cancer: a comparison of three palliative methods. J Surg Oncol 2013;108:537-541.   DOI